BACKGROUND: Although human bocavirus type 1 (HBoV1) is a respiratory pathogen, presence of HBoV-DNA in secretions of asymptomatic children raised the question on the significance of HBoV-positive results. METHODS: Archived specimens from a prospective, longitudinal study were tested for HBoV. A total of 94 children (aged 6-36 months) were HBoV(+) during 172 upper respiratory tract infection (URI) and/or acute otitis media (AOM) episodes. We used pyrosequencing of NP1, VP1 and VP2 genes to type HBoV and subtype HBoV1 in these specimens. RESULTS: Of the specimens tested, HBoV-DNA were successfully sequenced in 128 (74%) samples from 70 children; all were HBoV type 1. Subtypes identified (n = 108) were LWK/TW (63%), LWK/BJ (20%), Bonn/BJ (16%) and LWK/KU3 (1%). Of 46 children for whom shedding pattern could be determined, viral clearance within 30 days (13-29 days) occurred in 28%; another 22% of children had no recurrence after 32-267 days. Prolonged virus presence of >30 days (34-181 days+) occurred in 22%; intermittent detection (61+ to 170+ days) in 20%. Infection with the same HBoV1 subtype after 4-5 negative samples (244 and 265 days interval) occurred in 4%. Infection with 2 different HBoV1 subtypes (29 and 87 days apart) occurred in only 4%. Newly acquired HBoV1-URI resulted in AOM in 53% of cases. CONCLUSIONS: Children with HBoV1 infection commonly shed for a prolonged period leading to repeated viral DNA detection. Recurrence after 8-9 months suggests possible persistence and reactivation. Infections with 2 different HBoV1 subtypes within 1-year period are uncommon. Newly acquired HBoV1-URI is often complicated by AOM.
BACKGROUND: Although human bocavirus type 1 (HBoV1) is a respiratory pathogen, presence of HBoV-DNA in secretions of asymptomatic children raised the question on the significance of HBoV-positive results. METHODS: Archived specimens from a prospective, longitudinal study were tested for HBoV. A total of 94 children (aged 6-36 months) were HBoV(+) during 172 upper respiratory tract infection (URI) and/or acute otitis media (AOM) episodes. We used pyrosequencing of NP1, VP1 and VP2 genes to type HBoV and subtype HBoV1 in these specimens. RESULTS: Of the specimens tested, HBoV-DNA were successfully sequenced in 128 (74%) samples from 70 children; all were HBoV type 1. Subtypes identified (n = 108) were LWK/TW (63%), LWK/BJ (20%), Bonn/BJ (16%) and LWK/KU3 (1%). Of 46 children for whom shedding pattern could be determined, viral clearance within 30 days (13-29 days) occurred in 28%; another 22% of children had no recurrence after 32-267 days. Prolonged virus presence of >30 days (34-181 days+) occurred in 22%; intermittent detection (61+ to 170+ days) in 20%. Infection with the same HBoV1 subtype after 4-5 negative samples (244 and 265 days interval) occurred in 4%. Infection with 2 different HBoV1 subtypes (29 and 87 days apart) occurred in only 4%. Newly acquired HBoV1-URI resulted in AOM in 53% of cases. CONCLUSIONS:Children with HBoV1infection commonly shed for a prolonged period leading to repeated viral DNA detection. Recurrence after 8-9 months suggests possible persistence and reactivation. Infections with 2 different HBoV1 subtypes within 1-year period are uncommon. Newly acquired HBoV1-URI is often complicated by AOM.
Authors: Tobias Allander; Martti T Tammi; Margareta Eriksson; Annelie Bjerkner; Annika Tiveljung-Lindell; Björn Andersson Journal: Proc Natl Acad Sci U S A Date: 2005-08-23 Impact factor: 11.205
Authors: Tuomas Jartti; Klaus Hedman; Laura Jartti; Olli Ruuskanen; Tobias Allander; Maria Söderlund-Venermo Journal: Rev Med Virol Date: 2011-10-28 Impact factor: 6.989
Authors: Ronald Dijkman; Sylvie M Koekkoek; Richard Molenkamp; Oliver Schildgen; Lia van der Hoek Journal: J Virol Date: 2009-05-27 Impact factor: 5.103
Authors: Liisa Lehtoranta; Maria Söderlund-Venermo; Johanna Nokso-Koivisto; Hanna Toivola; Karin Blomgren; Katja Hatakka; Tuija Poussa; Riitta Korpela; Anne Pitkäranta Journal: Int J Pediatr Otorhinolaryngol Date: 2011-11-26 Impact factor: 1.675
Authors: Robert Schlaberg; Krow Ampofo; Keith D Tardif; Chris Stockmann; Keith E Simmon; Weston Hymas; Steven Flygare; Brett Kennedy; Anne Blaschke; Karen Eilbeck; Mark Yandell; Jon A McCullers; Derek J Williams; Kathryn Edwards; Sandra R Arnold; Anna Bramley; Seema Jain; Andrew T Pavia Journal: J Infect Dis Date: 2017-09-15 Impact factor: 5.226
Authors: Maria Mathisen; Sudha Basnet; Andreas Christensen; Arun K Sharma; Garth Tylden; Sidsel Krokstad; Palle Valentiner-Branth; Tor A Strand Journal: Microbiol Spectr Date: 2021-10-27